{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fneurologypodcast.simplecast.com%2Fepisodes%2F2024-lai-podcast-j_X9PsFo","width":444,"version":"1.0","type":"rich","title":"Reaching Patients Where They Are: Experience With LAI Antipsychotics in Community Practice","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/c52434e0-cdd2-4c97-b4e1-526a9e0f7fa9/7638-lai-me-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/a4216986-a45d-4b38-9d62-0920b38f8814\" height=\"200\" width=\"100%\" title=\"Reaching Patients Where They Are: Experience With LAI Antipsychotics in Community Practice\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Dr Robert Cotes and Dr David Goldsmith, Codirectors of the Clinical and Research Program for Psychosis at Grady, part of the Emory University School of Medicine in Atlanta, discuss their clinical experience with long-acting injectable antipsychotic treatments, with a focus on communication strategies to educate patients on their treatment options and engage them in shared decision-making."}